2010 Research Report on investigation of Chinese medical and Pharmaceutical Contract Research Organization (CRO) market

The report begins with the highlighted research factors : the rapid development of CRO service, the successful listing of PharmaTech in America, the bright prospect of China' s CRO market. Meanwhile the history and development together with the service range are briefly illuminated.

The report profiles the research foundation of global medical industry together with the scale and prospect of global CRO service. It also combines the business structure with trends of global CRO service to analyze on CRO market in main districts and global leading CRO enterprises. Domestic competitive CRO enterprises are also presented in this report.
[Studien Infos ausblenden]

The research foundation of CRO 5
1.The definition of CRO industry 5
2.The emergence of CRO 5
3.The service range of CRO 7

CHAPTER ONE THE ANALYSIS OF GLOBAL CRO INDUSTRY MARKET 8

Section I The analysis of the development of CRO industry 8
1.The sales scale of global pharmaceutical market (2009-2010) 8
2. Top ten of global enterprises which invest into the research and development of new drugs (2007) 9
3. Top fifteen of global enterprises which invest into the research and development (2008-2009) 10

Section II The analysis of the scales of global CRO markets 16
1. The analysis of global R & D expenses on new drugs (2009-2012) 16
2. The scale of global CRO market (2009-2012) 16
3. The prospect of global R & D outsourcing of new drugs 17

Section III The analysis of CRO market structure in 2009 19
1.The analysis of R & D outsourcing of new drugs 19
2.The business structure of new drugs R & D outsourcing 20
3.The characteristics of the business structure of new drugs R & D outsourcing service 22

Section IV The analysis of CRO local market in 2009 24
1. The structure of global CRO market 24
2. The analysis of American CRO industy 25
3. The analysis of Indian CRO market 29
4. The analysis of CRO market in Taiwan 30

Section V The structure of the competition between CRO enterprises in 2009 31
1. The analysis of global CRO enterprises 32
2. The scan of the world's top CRO companies 34

CHAPTER TWO THE ANALYSIS OF CHINESE CRO MARKET 35

Section I The analysis of the development of Chinese CRO 36
1.The development of CRO in China 36
2.The prospects of CRO in China 37

Section II The analysis of domestic CRO market 38
1. Chinese CRO market between 2006 and 2009 39
2.The analysis of the business structure of domestic enterprises 40

Section III The competition structure of domestic CRO marke 41
1.The types of the characteristics of domestic CRO enterprises 42
2.The types of the business of domestic CRO enterprises 43
3. The domestic CRO companies 43
4. Zhongguancun biomedical R & D outsourcing Union (CRO) 46
5.The biomedical R & D outsourcing center in Shanghai Pudong New Area 48

Section V The latest trends of the industry between 2009 and 2010 49
1. NovaMed completes financing the second round of venture capital 49
2. Sundia completes financing the second round venture capital in January of 2010 50
3. NovaSecta joins Chinese pharmaceutical R & D outsourcing company Union for the first time 51

CHAPTER TREE THE ANALYSIS OF DOMESTIC KEY ENTERPRISES 51

Section I Pharma Tech 51
1.The introduction of the enterprise 52
2.The SWOT analysis of competitiveness 52
3.The analysis of the financial operation in 2009 56

Section II The analysis of other enterprises 62
1.Shanghai Chempartner Co. Ltd. 62
2.Sandia medical technology (Shanghai) 63
3.Beijing MDS 64
4.Beijing KendleWits Medicine 67
5. Beijing Excel Medical Technology Development Co. Ltd. 67
6. Beijing Venturepharm Technology Co., Ltd. 69
7. Guangzhou Bo Ji State new drugs clinical research center 76
8. PHARMARON (Beijing) new drugs Technology Co., Ltd. 80

Notice 81
[Inhaltsverzeichnis ausblenden]

TABLE 1 TOP TEN OF GLOBAL ENTERPRISES WHICH INVEST INTO R & D OF NEW DRUGS (2007) 9
TABLE 2 THE TREND OF GLOBAL ENTERPRISES WHICH INVEST INTO R & D (2008-2009) 10
TABLE 3 THE MARKET GROWTH OF CRO OF GLOBAL PHARMACEUTICAL
INDUSTRIES (UNIT: 100 MILLION U.S. DOLLARS) 18
TABLE 4 THE GLOBAL CRO MARKET SHARE (UNIT: 100 MILLION U.S. DOLLARS; %) 24
TABLE 5 THE SALES VOLUME OF GLOBALLY KEY CRO ENTERPRISES IN 2009 32
TABLE 6 MAIN GLOBAL CRO INSTITUTES AND THEIR BUSINESS DIRECTIONS 33
TABLE 7 THE LIST OF PART OF DOMESTIC CRO ENTERPRISES • 43
TABLE 8 SPONSORS OF ZHONGGUANCUN BIOMEDICAL R & D OUTSOURCING UNION (ALL IN RANDOM ORDER) 47
TABLE 9 PART OF ENTERPRISES ENGAGING IN BIOMEDICAL R & D OUTSOURCING SERVICE IN SHANGHAI PUDONG NEW AREA 48
TABLE 10 THE SWOT ANALYSIS OF PHARMATECH 52
TABLE 11 THE PROJECTS COMPLETED BY VPS 72
TABLE 12 THE PROJECTS WHICH ARE BEING OPERATED BY VPS 72

FIGURE 1 THE TREND OF THE GLOBAL CRO MARKET (2009-2012) 17
FIGURE 2 THE SCALE MAP OF THE OUTSOURCING MARKET VALUE OF NEW DRUGS R & D IN 2009 20
FIGURE 3 THE SCALE MAP OF THE OUTSOURCING MARKET VALUE OF NEW DRUGS R & D 21
FIGURE 4 THE MARKET SHARE OF GLOBAL LEADING INTERNATIONAL CRO SECTORS ?2003? 33
FIGURE 5 THE TREND OF CHINESE CRO MARKET BETWEEN 2006 AND 2009 (UNIT: HUNDRED MILLION YUAN) 39
FIGURE 6 THE REVENUE CHANGE OF (UNIT: MILLION DOLLARS) 64
FIGURE 7 THE REGIONAL RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN 2009 65
FIGURE 8 THE RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN TERMS OF DIFFERENT CUSTOMES IN 2009 65
FIGURE 9 THE RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN TERMS OF DIFFERENT BUSINESS STRUCTURES IN 2009 66
[Tabellenverzeichnis ausblenden]